Astena Holdings Co

Astena Holdings Co EBIT per Share

The EBIT per Share of Astena Holdings Co (8095.T) as of Nov 3, 2026 is 74.86 JPY. In the previous year, EBIT per Share was 69.95 JPY — a change of 7.01% (higher).

EBIT per Share

74.86JPY

YoY

7.01%

Last updated:

EBIT per Share of Astena Holdings Co is 2025 74.86 JPY. EBIT per Share of Astena Holdings Co was 2024 69.95 JPY. It decreases by 7.01% higher compared to the previous year.

The Astena Holdings Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
64.80 JPY
Jan 1, 2020
60.84 JPY
Jan 1, 2021
66.75 JPY
Jan 1, 2022
20.77 JPY
Jan 1, 2023
28.56 JPY
Jan 1, 2024
69.95 JPY
Jan 1, 2025
74.86 JPY
Jan 1, 2026 (e)
0.00 JPY
The Astena Holdings Co EBIT per Share history
YEAREBIT per ShareYoY
est0.00JPY-100.00%
74.86JPY+7.01%
69.95JPY+144.92%
28.56JPY+37.49%
20.77JPY-68.88%
66.75JPY+9.72%
60.84JPY-6.11%
64.80JPY+13.69%
56.99JPY+16.78%
48.81JPY+66.07%
29.39JPY+77.31%
16.57JPY-37.15%
26.37JPY-11.60%
29.83JPY-10.54%
33.35JPY-7.31%
35.98JPY+74.95%
20.56JPY+64.55%
12.50JPY+2,287.68%
0.52JPY-92.39%
6.88JPY-26.46%
9.35JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Astena Holdings Co Stock analysis

What does Astena Holdings Co do? Astena Holdings Co., Ltd. generates revenue through four business segments. The Fine Chemicals segment sells pharmaceutical raw materials and pharmaceuticals to manufacturers. The Medical segment produces and sells pharmaceutical products directly to healthcare providers. The HBC and Food segment offers cosmetic raw materials, functional food raw materials, general use medicines, and cosmetics to retailers and distributors. The Industrial Chemicals segment supplies electronic industry chemicals, surface treatment chemicals, and related products to manufacturing plants and printed circuit board producers. Consulting services form part of the other businesses segment, providing additional revenue streams. The company's products target pharmaceutical manufacturers, healthcare providers, retailers, distributors, and industrial manufacturing plants. These segments include pharmaceutical raw material suppliers, medical product distributors, cosmetic and food raw material buyers, and electronics industry chemical users. The firm's sales are driven by direct B2B transactions across these diverse industrial and consumer markets. Astena's revenue streams are diversified across pharmaceutical, medical, cosmetic, food, and industrial chemical markets. The Fine Chemicals and Medical segments focus on healthcare-related products, while HBC and Food serves both cosmetic and food industries. Industrial Chemicals caters to electronics manufacturing needs. Consulting services complement the core product lines, enhancing the company's market presence across multiple sectors. Astena Holdings Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Astena Holdings Co stock

EBIT per Share of Astena Holdings Co is 74.86 JPY in 2025.

EBIT per Share of Astena Holdings Co changed from 69.95 JPY to 74.86 JPY, representing a 7.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Astena Holdings Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Astena Holdings Co

All Key Metrics — Astena Holdings Co